TechFormer ByteDance AI scientist touts drug-discovery model said to lead global peers
A new life sciences AI model from a venture founded by a former ByteDance scientist has topped a third-party benchmark in several drug-discovery tasks, founder Quanquan Gu said. The company claims NovaAtom-Lite outperforms state-of-the-art systems.
Former ByteDance AI scientist touts drug-discovery model said to lead global peers
Tech